Related Experiment Video

Updated: Jul 10, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Microtubule disruption and tumor suppression by mitogen-activated protein kinase phosphatase 4

Yuangang Liu1, James Lagowski, Aaron Sundholm

  • 1Department of Dermatology, Oregon Health and Science University, Portland, Oregon 97239, USA. liuy@ohsu.edu

Cancer Research
|November 17, 2007
PubMed

Insights

Mitogen-activated protein kinase phosphatase 4 (MKP4) loss is linked to skin cancer. Restoring MKP4 expression suppresses tumor growth by disrupting microtubules, suggesting new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Extracellular signal-regulated kinase (Erk) pathway is crucial for cancer cell proliferation and survival.
  • Mitogen-activated protein kinase (MAPK) phosphatases (MKPs) regulate Erk activity via a negative feedback loop.
  • Early alterations in the Ras pathway are key in epidermal carcinogenesis.

Purpose of the Study:

  • To investigate the role of MKP4, a cytosolic MKP, in epidermal carcinogenesis.
  • To determine the association of MKP4 down-regulation with squamous cell carcinoma (SCC) development.
  • To explore the therapeutic potential of MKP4 reconstitution in malignant tumor cells.

Main Methods:

  • Identification and characterization of MKP4 in a clonal model of epidermal carcinogenesis.
  • Analysis of MKP4 expression levels in relation to tumor progression (benign vs. malignant).
  • Reconstitution of MKP4 expression in malignant tumor cells and assessment of its effects on cell death and tumor suppression.

Main Results:

  • MKP4 was identified as a cytosolic MKP with specificity for Erk, c-jun-NH(2)-kinase, and p38.
  • MKP4 expression was down-regulated during epidermal carcinogenesis initiation and lost during malignant conversion, independent of Ras mutation.
  • Loss of MKP4 correlated with SCC development and MKP4 reconstitution induced G(2)-M cell death and microtubule disruption, suppressing tumor growth.

Conclusions:

  • MKP4 plays a significant role in suppressing squamous cell carcinoma.
  • MKP4-mediated microtubule disruption offers a novel mechanism for tumor suppression.
  • Combined MAPK inhibition strategies mimicking MKP4 function present a potential therapeutic avenue for cancer treatment.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...